238 related articles for article (PubMed ID: 27702880)
1. Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.
Valable S; Corroyer-Dulmont A; Chakhoyan A; Durand L; Toutain J; Divoux D; Barré L; MacKenzie ET; Petit E; Bernaudin M; Touzani O; Barbier EL
J Cereb Blood Flow Metab; 2017 Jul; 37(7):2584-2597. PubMed ID: 27702880
[TBL] [Abstract][Full Text] [Related]
2. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
[TBL] [Abstract][Full Text] [Related]
3. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.
Corroyer-Dulmont A; Pérès EA; Petit E; Durand L; Marteau L; Toutain J; Divoux D; Roussel S; MacKenzie ET; Barré L; Bernaudin M; Valable S
Biol Chem; 2013 Apr; 394(4):529-39. PubMed ID: 23399636
[TBL] [Abstract][Full Text] [Related]
5. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
6. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Tumor Hypoxia Metrics Derived from
Scarpelli ML; Healey DR; Fuentes A; Kodibagkar VD; Quarles CC
Tomography; 2020 Dec; 6(4):379-388. PubMed ID: 33364428
[No Abstract] [Full Text] [Related]
9. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
11. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
[TBL] [Abstract][Full Text] [Related]
12. Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.
Chakhoyan A; Corroyer-Dulmont A; Leblond MM; Gérault A; Toutain J; Chazaviel L; Divoux D; Petit E; MacKenzie ET; Kauffmann F; Delcroix N; Bernaudin M; Touzani O; Valable S
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2270-2282. PubMed ID: 27496553
[TBL] [Abstract][Full Text] [Related]
13. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
[TBL] [Abstract][Full Text] [Related]
14. Brain hypoxia mapping in acute stroke: Back-to-back T2' MR versus
Jensen-Kondering U; Manavaki R; Ejaz S; Sawiak SJ; Carpenter TA; Fryer TD; Aigbirhio FI; Williamson DJ; Baron JC
Int J Stroke; 2017 Oct; 12(7):752-760. PubMed ID: 28523963
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.
Karsy M; Gillespie DL; Horn KP; Burrell LD; Yap JT; Jensen RL
Methods Mol Biol; 2018; 1742():301-320. PubMed ID: 29330810
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma.
Linnik IV; Scott ML; Holliday KF; Woodhouse N; Waterton JC; O'Connor JP; Barjat H; Liess C; Ulloa J; Young H; Dive C; Hodgkinson CL; Ward T; Roberts D; Mills SJ; Thompson G; Buonaccorsi GA; Cheung S; Jackson A; Naish JH; Parker GJ
Magn Reson Med; 2014 May; 71(5):1854-62. PubMed ID: 23798369
[TBL] [Abstract][Full Text] [Related]
17. Tissue oxygen saturation mapping with magnetic resonance imaging.
Christen T; Bouzat P; Pannetier N; Coquery N; Moisan A; Lemasson B; Thomas S; Grillon E; Detante O; Rémy C; Payen JF; Barbier EL
J Cereb Blood Flow Metab; 2014 Sep; 34(9):1550-7. PubMed ID: 25005878
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
[TBL] [Abstract][Full Text] [Related]
19. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
20. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
